Stockreport

Australia's CSL stands by profit guidance due to strong demand for blood products [Reuters]

CSL LTD SP/ADR  (CSLLY) 
NASDAQ:AMEX Investor Relations: csl.com/investors
PDF Australia's CSL stands by profit guidance due to strong demand for blood products (Reuters) - Australian plasma and vaccine specialist CSL Ltd said it was standing by pr [Read more]